Article
Programming T cells for Early Cancer Detection with Customized Protease-Activatable Receptors
2026-01-20
Abstract excerpt
Early cancer detection has the potential to reduce cancer mortality, yet endogenous tumor-shed biomarkers lack sensitivity for early-stage disease. We report OncoSCOUT, a cancer detection strategy using T cells engineered with protease-activatable receptors (PARs) that conditionally recognize tumor cells and release a synthetic biomarker for detection in urine. These PARs comprise masked synthetic Notch receptors...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 73fc3e7c-3993-5013-b9fc-c4ed46078b62
- DOI
- 10.64898/2026.01.16.699939
